Cargando…

How likely are COVID-19 interventions to benefit the sickest patients?

Detalles Bibliográficos
Autores principales:	Perner, Anders, Tirupakuzhi Vijayaraghavan, Bharath Kumar, Venkatesh, Balasubramanian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280679/ https://www.ncbi.nlm.nih.gov/pubmed/32519004 http://dx.doi.org/10.1007/s00134-020-06131-1

Ejemplares similares

EXTRACORPOREAL MEMBRANE OXYGENATION: A HOPE FOR THE SICKEST PATIENTS WITH COVID-19
por: ARSHAD, ALEENA, et al.
Publicado: (2022)

Sepsis Epidemiology and Outcomes in Asia: Advancing the Needle
por: Tirupakuzhi Vijayaraghavan, Bharath Kumar, et al.
Publicado: (2022)

Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID‐19 and severe hypoxaemia—Post hoc exploratory analyses of the COVID STEROID 2 trial
por: Granholm, Anders, et al.
Publicado: (2022)

Dying to live, the story of Grant McIntyre, COVID's sickest patient
Publicado: (2021)

Challenges in operationalising clinical trials in India during the COVID-19 pandemic
por: Bassi, Abhinav, et al.
Publicado: (2022)

Concerns about subgroup analyses and reason for stopping remdesivir trial
por: Vijayaraghavan, Bharath Kumar Tirupakuzhi
Publicado: (2022)

The impact of Coronavirus 19 disease on liver transplantation in France: The sickest first approach?
por: Mazzola, Alessandra, et al.
Publicado: (2020)

Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
por: Perner, Anders, et al.
Publicado: (2023)

Liver injury in COVID-19: prevalence and association with patient-centered outcomes- an analysis of the international severe acute respiratory and emerging infection consortium (ISARIC) database
por: Bishnu, Saptarshi, et al.
Publicado: (2022)

Clinician preferences for prescription of corticosteroids in patients with septic shock: an international survey
por: Hammond, Naomi E., et al.
Publicado: (2023)

Survivorship and (QALY)ty: In Pursuit of a Mirage?
por: Vijayaragavan, Bharath Kumar Tirupakuzhi, et al.
Publicado: (2019)

Critical Care Registries: The Next Big Stride?
por: Vijayaraghavan, Bharath Kumar Tirupakuzhi, et al.
Publicado: (2019)

Breaking Barriers to Reach Farther: A Call for Urgent Action on Tele-ICU Services
por: Ramakrishnan, Nagarajan, et al.
Publicado: (2020)

Critical Care Epidemiology and Research in the Face of a Pandemic: An Opportunity in a Crisis
por: Vijayaraghavan, Bharath Kumar Tirupakuzhi, et al.
Publicado: (2020)

Can we identify futility of care in the sickest critically ill patients on the third ICU day?
por: Afessa, B, et al.
Publicado: (2004)

Fluid Resuscitation in Sepsis: Reexamining the Paradigm
por: Madhusudan, Poorna, et al.
Publicado: (2014)

Improving Mobility in Critically Ill Patients in a Tertiary Care ICU: Opportunities and Challenges
por: Mohan, Sneha, et al.
Publicado: (2021)

Does Aggressive Phototherapy Increase Mortality while Decreasing Profound Impairment among the Smallest and Sickest Newborns?
por: Tyson, Jon E, et al.
Publicado: (2012)

Do HIV treatment eligibility expansions crowd out the sickest? Evidence from rural South Africa
por: Kluberg, Sheryl A., et al.
Publicado: (2018)

Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial
por: Tirupakuzhi Vijayaraghavan, Bharath Kumar, et al.
Publicado: (2020)

Standard Care Versus Awake Prone Position in Adult Nonintubated Patients With Acute Hypoxemic Respiratory Failure Secondary to COVID-19 Infection—A Multicenter Feasibility Randomized Controlled Trial
por: Jayakumar, Devachandran, et al.
Publicado: (2021)

Time for tocilizumab in COVID-19?
por: Butler, Ethan, et al.
Publicado: (2021)

Validation of a simplified risk prediction model using a cloud based critical care registry in a lower-middle income country
por: Tirupakuzhi Vijayaraghavan, Bharath Kumar, et al.
Publicado: (2020)

COVID-19 Vaccination and Implementation Science: How One Can Benefit the Other
por: Zimmerman, Sheryl, et al.
Publicado: (2021)

The benefits of pulmonary rehabilitation in patients with COVID-19
por: He, Zhen-feng, et al.
Publicado: (2021)

Liver injury in hospitalized patients with COVID-19: An International observational cohort study
por: Tirupakuzhi Vijayaraghavan, Bharath Kumar, et al.
Publicado: (2023)

How Has It Benefitted the Profession of Texas?
Publicado: (1886)

Barriers and facilitators to the conduct of critical care research in low and lower-middle income countries: A scoping review
por: Tirupakuzhi Vijayaraghavan, Bharath Kumar, et al.
Publicado: (2022)

Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
por: Relan, Pryanka, et al.
Publicado: (2023)

Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from India
por: Tirupakuzhi Vijayaraghavan, Bharath Kumar, et al.
Publicado: (2022)

Notes on cost benefit of COVID‐19 lockdown
por: Mills, Michael, et al.
Publicado: (2020)

“Weighing” the risks and benefits – Thromboprophylaxis challenges in obese COVID-19 patients
por: Rokkam, Venkata Ram Pradeep, et al.
Publicado: (2020)

How to monitor the brain in COVID-19 patients?
por: Peluso, Lorenzo, et al.
Publicado: (2021)

20 years of Evidence‐Based Dentistry — How have our patients benefited?
por: Jokstad, Asbjorn
Publicado: (2018)

Reassessing the risks and benefits of COVID-19 precautions in 2023
por: Ollila, Thomas A., et al.
Publicado: (2023)

Health benefit and economic impact of utilising ECMO in COVID-19 patients: patient or cost first
por: Butt, Sundas, et al.
Publicado: (2023)

Added Benefit of Covid-19 Vaccination after Previous Infection
por: Klein, Nicola P.
Publicado: (2022)

Is the literature inconclusive about the harm from HES? No
por: Wiedermann, Christian J., et al.
Publicado: (2016)

Stress ulcer prophylaxis in adult neurocritical care patients—no firm evidence for benefit or harm
por: Krag, Mette, et al.
Publicado: (2016)

How to Start Interventional Radiology
por: Ghanaati, Hossein, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g7v7jbch2aaomcnr2f2mrataqe